These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30610818)

  • 1. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
    Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
    J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
    de Martino M; Taus C; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
    Mol Carcinog; 2016 Oct; 55(10):1458-66. PubMed ID: 26294352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
    Li JJ; Zheng PCJ; Wang YZ
    World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte telomere length and
    Morais M; Dias F; Resende T; Nogueira I; Oliveira J; Maurício J; Teixeira AL; Medeiros R
    Future Oncol; 2020 Jun; 16(18):1245-1255. PubMed ID: 32422075
    [No Abstract]   [Full Text] [Related]  

  • 5. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma.
    Ge P; Yu X; Wang ZC; Lin J
    Asian Pac J Cancer Prev; 2015; 16(9):4071-5. PubMed ID: 25987089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
    Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
    Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
    Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
    Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hTERT expression in sporadic renal cell carcinomas.
    Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
    J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Rasti A; Shariftabrizi A; Mehrazma M; Fodstad Ø; Asgari M
    Pathology; 2019 Jan; 51(1):21-31. PubMed ID: 30466948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hTERT expression by MAP kinase inhibitor induces cell death in renal cell carcinoma.
    Pal D; Sharma U; Singh SK; Kakkar N; Prasad R
    Urol Oncol; 2017 Jun; 35(6):401-408. PubMed ID: 28215740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TERT promoter mutations in clear cell renal cell carcinoma.
    Hosen I; Rachakonda PS; Heidenreich B; Sitaram RT; Ljungberg B; Roos G; Hemminki K; Kumar R
    Int J Cancer; 2015 May; 136(10):2448-52. PubMed ID: 25331263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P14 methylation: an epigenetic signature of salivary gland mucoepidermoid carcinoma in the Serbian population.
    Nikolic N; Carkic J; Ilic Dimitrijevic I; Eljabo N; Radunovic M; Anicic B; Tanic N; Falk M; Milasin J
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jan; 125(1):52-58. PubMed ID: 29079368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of the detection of hTERT mRNA in renal tumors.
    Martínez-Sanchíz C; García-Olmo DC; Picazo-Martínez MG; Nam-Cha SY; Giménez-Bachs JM; Flores-Bautista AB; Díaz-Piqueras Á; Salinas-Sánchez AS
    Urol Oncol; 2019 Oct; 37(10):749-757. PubMed ID: 30975552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
    Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
    Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.
    Wang K; Liu T; Liu L; Liu J; Liu C; Wang C; Ge N; Ren H; Yan K; Hu S; Björkholm M; Fan Y; Xu D
    Oncotarget; 2014 Apr; 5(7):1829-36. PubMed ID: 24742867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.
    Khaliq S; Ajaz S; Firasat S; Shahid S; Hasan AS; Sultan G; Mohsin R; Hashmi A; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Abid A
    Mutat Res; 2014; 763-764():45-52. PubMed ID: 24727139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.